Navitor™ TAVI

Transcatheter Aortic Valve Implantation (TAVI)

Navitor TAVI System

Welcome to the forefront of cardiac care with the Navitor TAVI System. Our commitment to innovation, patient safety, and clinical excellence makes us the preferred choice for transcatheter aortic valve implantation (TAVI*) procedures worldwide. The Navitor TAVI System offers stable delivery, remarkable performance, and is future ready.

Stable delivery.

  • The confidence of controlled deployment.
  • Largest valve. Smallest delivery system to date.2
  • Three large and highly visible radiopaque markers.

Remarkable performance.1

  • 0% Moderate to Severe PVL
  • 2.0 cm² Effective Orifice Area
  • 7.4 mmHg Mean Gradient
  • 1.9% All-Cause Mortality
  • 1.9% Disabling Stroke
  • 3.8% Life-Threatening Bleeding
  • 1.9% Acute Kidney Injury Stage 2/3
  • 4.2% Major Vascular Complications  

Future ready.

  • Uncompromised coronary access
  • Future ready index valve
Navitor FlexNav

Ordering Information

Navitor™ Transcatheter Aortic Valve

Catalog NumberValve Size (mm)Annulus Use Range Diameter (mm)6Annulus Area (mm²)6Annulus Perimeter (mm)6


FlexNav™ Delivery System

Catalog NumberEquivalent Integrated Sheath Diameter
Valve Capsule Outer Diameter
Integrated Sheath Working Length
Delivery System Working Length
Minimum Vessel Diameter Requirement
FNAV-DS-SM146.030107≥ 5.0
FNAV-DS-LG156.330107≥ 5.5


Navitor™ Loading System

Catalog Number 
NVTR-LS-SMThe Navitor™ loading system facilitates valve preparation/loading onto the FlexNav™ delivery system. The loading system includes a loading funnel, loading base, base insert, loading tube, stent guide and leaflet tester. The SM and LG+ loading systems contain base inserts to facilitate loading the Navitor valve according to the labeled size on the base insert. In addition, the base insert and loading tube are color-coded to differentiate between the different configurations.

* Also referred to as TAVR (Transcatheter Aortic Valve Replacement)
 30-Day Echo Core Lab Data


  1. Navitor™ TAVI System IFU.
  2. Abbott data on file 90734545/90465559.

Rx Only

Important Safety Information



The Navitor™ Transcatheter Aortic Valve Implantation System is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical comorbidities unmeasured by the STS risk calculator).


The valve is contraindicated for patients with inability to tolerate antiplatelet/anticoagulant therapy or nitinol alloy (nickel and titanium), or who have active infections, including endocarditis.

Potential Adverse Events

Adverse events potentially associated with the use of transcatheter bioprosthetic heart valves include but are not limited to: access site complications (e.g., pain, bleeding, infection, hematoma, pseudoaneurysm, etc.); acute coronary obstruction; acute myocardial infarction; allergic reaction to antiplatelet agents, contrast medium, or valve components; aortic rupture; ascending aorta trauma; atrio-ventricular node block; cardiac arrhythmias; conduction system injury; conversion to open surgical procedure; death; dissection; embolism; emergent balloon valvuloplasty; emergent percutaneous coronary intervention (PCI); emergent surgery (i.e., coronary artery bypass, heart valve replacement); endocarditis; explantation; heart failure; hemodynamic compromise; hemolysis; hemolytic anemia; hemorrhage; hypotension or hypertension; infection; myocardial ischemia; mitral valve insufficiency; multi-organ failure; non-structural dysfunction (i.e., entrapment by pannus, paravalvular leak, inappropriate sizing or positioning); pannus; pericardial effusion; perforation of the myocardium, ventricle, or a blood vessel; permanent disability; permanent pacemaker; regurgitation; renal insufficiency or renal failure; reoperation; respiratory failure; sepsis; stroke; structural deterioration (i.e., calcification, leaflet tear); thrombosis; tamponade; transfusion; valve embolization or migration; vessel dissection or spasm.

MAT-2300253 v2.0